Merck
CN
HomeWebinarsLatest Advancements of Melt-based 3D Printing Technologies for Oral Drug Delivery

Latest Advancements of Melt-based 3D Printing Technologies for Oral Drug Delivery



WEBINAR

The application of polymer excipients in 3D printing manufacturing is usually limited due to the concerns of filament strength, high processing temperature and large-scale manufacturing. Latest technology developments are targeting a direct melt deposition to simplify the process and enable a constant and efficient process. Two different processing approaches will be presented: The advanced melt drop deposition, where individual three-dimensional geometries can be created by deposition of polymer droplets, and the MED® 3D printing technology which allows precise layer-by-layer deposition to produce objects with well-designed geometric structures.

In this webinar, you will learn:

  • Latest advancements of melt-based 3D printing approaches
  • Application examples for the individual technologies
  • Deep dive in the MED® 3D printing technology to design dedicated drug release profiles
  • Excipient requirements for 3D printing technology

Speakers

Thomas Kipping, Ph.D.

Thomas Kipping, Ph.D.

Merck

Head of Drug Carriers

Dr. Thomas Kipping is an expert in the field of pharmaceutical technology and formulation development. Thomas is currently the head of drug carriers at Merck. With more than 10 years of industrial experience, spanning various sectors within the pharmaceutical industry, including drug product development and CDMO services, he has consistently demonstrated a strong commitment to advancing pharmaceutical sciences and enhancing drug development processes He holds a Ph.D. in pharmaceutical technology from the University of Bonn.

Xianghao Zuo, Ph.D.

Xianghao Zuo, Ph.D.

Triastek, Inc.

Deputy Director of R&D

Xianghao Zuo received his Ph.D. in materials science and engineering at Stony Brook University. He is now the deputy director of R&D at Triastek, Inc., specializing in developing 3D-printed drug products and improving the solubility and bioavailability of poorly soluble drugs.

Webinar Information

Pharma and biopharma manufacturing

  • Solid Formulation Strategies
  • Duration:1h

  • Language:English

  • Session 1:presented June 23, 2022

    Watch Now


Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?